Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

High-affinity, selective human A3 receptor radioligand: synthesis and preliminary testing

Feb. 28, 2000

Oxford BioMedica to collaborate with AstraZeneca in drug discovery

Feb. 25, 2000

Corixa subscribes to Incyte's LifeSeq Gold database

Feb. 24, 2000

BIIE-0246, the first selective nonpeptide neuropeptide Y Y2 antagonist

Feb. 22, 2000

Strategic collaboration formed by 3-D and DuPont

Feb. 18, 2000

Medarex and Eos Biotechnology establish genomics-based antibody drug alliance

Feb. 17, 2000

Exelixis delivers target for screening to Pharmacia & Upjohn

Feb. 15, 2000

Human Genome Sciences and Praecis enter agreement for small-molecule drug discovery

Feb. 11, 2000

Alkermes and Glaxo Wellcome form pulmonary drug delivery collaboration

Feb. 10, 2000

Generex receives U.S. patent for large-molecule pharmaceutical delivery

Feb. 9, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 26, 2026.
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026